Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

The lotion helps manage mild to moderate hair loss.

AC5 improves hair loss and hair quality with high satisfaction rates.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Spironolactone is generally safe and effective for treating hair loss in women, but may be less effective in severe cases.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

A 20-month-old girl had a rare adrenal tumor removed successfully, with no recurrence for 10 years.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

The new gel for hair loss is safe, effective, and reduces side effects.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Letrozole reduces seizures but not brain damage in mice.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Anti-androgens can help reduce the effects of male hormones on the skin.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Taking spironolactone doesn't increase the chance of breast cancer coming back.